Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Person
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Commissioner_of_Food_and_Drugs
|
| gptkbp:affiliation |
gptkb:Duke_University
|
| gptkbp:awards |
FDA Commissioner’s Special Citation
|
| gptkbp:birth_date |
August 28, 1951
|
| gptkbp:birth_place |
gptkb:North_Carolina
|
| gptkbp:children |
2
|
| gptkbp:education |
gptkb:Duke_University_School_of_Medicine
gptkb:University_of_North_Carolina_at_Chapel_Hill |
| gptkbp:field |
cardiology
regulatory science |
| https://www.w3.org/2000/01/rdf-schema#label |
Robert M. Califf
|
| gptkbp:known_for |
clinical trials
|
| gptkbp:occupation |
gptkb:hospital
|
| gptkbp:position |
gptkb:Commissioner_of_Food_and_Drugs
|
| gptkbp:research_focus |
gptkb:legislation
drug development |
| gptkbp:spouse |
gptkb:Kathy_Califf
|
| gptkbp:term_end |
present
January 20, 2017 |
| gptkbp:term_start |
February 2022
February 17, 2016 |